These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7686641)
1. alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease. Van Gool D; De Strooper B; Van Leuven F; Triau E; Dom R Neurobiol Aging; 1993; 14(3):233-7. PubMed ID: 7686641 [TBL] [Abstract][Full Text] [Related]
2. Amyloid precursor protein accumulation in Lewy body dementia and Alzheimer's disease. Van Gool D; De Strooper B; Van Leuven F; Dom R Dementia; 1995; 6(2):63-8. PubMed ID: 7606281 [TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia. Van Gool D; David G; Lammens M; Baro F; Dom R Dementia; 1993; 4(6):308-14. PubMed ID: 8136893 [TBL] [Abstract][Full Text] [Related]
4. Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease. Cummings BJ; Su JH; Cotman CW Exp Neurol; 1993 Dec; 124(2):315-25. PubMed ID: 8287930 [TBL] [Abstract][Full Text] [Related]
5. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease. Snow AD; Nochlin D; Sekiguichi R; Carlson SS Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929 [TBL] [Abstract][Full Text] [Related]
6. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease. Ferrer I; Freixas M; Blanco R; Carmona M; Puig B Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978 [TBL] [Abstract][Full Text] [Related]
7. Appearance of localized immunoreactivity for the alpha 4 integrin subunit and for fibronectin in brains from Alzheimer's, Lewy body dementia patients and aged controls. Van Gool D; Carmeliet G; Triau E; Cassiman JJ; Dom R Neurosci Lett; 1994 Mar; 170(1):71-3. PubMed ID: 8041517 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. Bauer J; Strauss S; Schreiter-Gasser U; Ganter U; Schlegel P; Witt I; Yolk B; Berger M FEBS Lett; 1991 Jul; 285(1):111-4. PubMed ID: 1712317 [TBL] [Abstract][Full Text] [Related]
9. The "nonamyloidogenic" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid. Lalowski M; Golabek A; Lemere CA; Selkoe DJ; Wisniewski HM; Beavis RC; Frangione B; Wisniewski T J Biol Chem; 1996 Dec; 271(52):33623-31. PubMed ID: 8969231 [TBL] [Abstract][Full Text] [Related]
10. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease. Stoltzner SE; Grenfell TJ; Mori C; Wisniewski KE; Wisniewski TM; Selkoe DJ; Lemere CA Am J Pathol; 2000 Feb; 156(2):489-99. PubMed ID: 10666378 [TBL] [Abstract][Full Text] [Related]
11. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain. Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760 [TBL] [Abstract][Full Text] [Related]
12. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease. Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of quantitating neurofilament-immunoreactive Alzheimer's disease lesions. de la Monte SM; Wands JR J Histochem Cytochem; 1994 Dec; 42(12):1625-34. PubMed ID: 7983363 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains. Schmidt ML; Lee VM; Forman M; Chiu TS; Trojanowski JQ Am J Pathol; 1997 Jul; 151(1):69-80. PubMed ID: 9212733 [TBL] [Abstract][Full Text] [Related]
15. Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain. Takahashi RH; Tobiume M; Sato Y; Sata T; Gouras GK; Takahashi H Neuropathology; 2011 Jun; 31(3):208-14. PubMed ID: 21062360 [TBL] [Abstract][Full Text] [Related]
16. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]
17. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Sheng JG; Mrak RE; Griffin WS Neuropathol Appl Neurobiol; 1995 Aug; 21(4):290-301. PubMed ID: 7494597 [TBL] [Abstract][Full Text] [Related]
18. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882 [TBL] [Abstract][Full Text] [Related]
19. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease. Schmidt ML; DiDario AG; Lee VM; Trojanowski JQ FEBS Lett; 1994 May; 344(1):69-73. PubMed ID: 8181568 [TBL] [Abstract][Full Text] [Related]
20. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. Dickson TC; Vickers JC Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]